121 related articles for article (PubMed ID: 21342381)
1. Positron emission tomography in non-medullary thyroid cancer.
Ho Shon I; Depcynzski B; Lin M; Clark JR; Wong V; Lin P; Campbell P
ANZ J Surg; 2011 Mar; 81(3):116-24. PubMed ID: 21342381
[TBL] [Abstract][Full Text] [Related]
2. Respective roles of thyroglobulin, radioiodine imaging, and positron emission tomography in the assessment of thyroid cancer.
Lind P; Kohlfürst S
Semin Nucl Med; 2006 Jul; 36(3):194-205. PubMed ID: 16762610
[TBL] [Abstract][Full Text] [Related]
3. Does recombinant human thyrotropin-stimulated positron emission tomography with [18F]fluoro-2-deoxy-D-glucose improve detection of recurrence of well-differentiated thyroid carcinoma in patients with low serum thyroglobulin?
Vera P; Kuhn-Lansoy C; Edet-Sanson A; Hapdey S; Modzelewski R; Hitzel A; d'Anjou J; Basuyau JP
Thyroid; 2010 Jan; 20(1):15-23. PubMed ID: 20017617
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of 18fluoro-2-deoxyglucose positron emission tomography in iodine scan negative, differentiated thyroid cancer recurrence.
Chisholm EJ; Tolley NS
J Laryngol Otol; 2009 Oct; 123(10):1145-9. PubMed ID: 19607742
[TBL] [Abstract][Full Text] [Related]
5. Assessment of the incremental value of recombinant thyrotropin stimulation before 2-[18F]-Fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography imaging to localize residual differentiated thyroid cancer.
Leboulleux S; Schroeder PR; Busaidy NL; Auperin A; Corone C; Jacene HA; Ewertz ME; Bournaud C; Wahl RL; Sherman SI; Ladenson PW; Schlumberger M
J Clin Endocrinol Metab; 2009 Apr; 94(4):1310-6. PubMed ID: 19158200
[TBL] [Abstract][Full Text] [Related]
6. Current role of radionuclide imaging in differentiated thyroid cancer.
Wong KT; Choi FP; Lee YY; Ahuja AT
Cancer Imaging; 2008 Sep; 8(1):159-62. PubMed ID: 18818134
[TBL] [Abstract][Full Text] [Related]
7. 18F-fluorodeoxyglucose positron emission tomography-computed tomography for suspected recurrent papillary thyroid cancer: early experience at Sunnybrook Health Sciences Centre.
Dahele M; Ung YC; Ehrlich L; Silverberg J; Balogh J; Wong CS
J Otolaryngol Head Neck Surg; 2008 Oct; 37(5):712-7. PubMed ID: 19128681
[TBL] [Abstract][Full Text] [Related]
8. Role of [(18)F]-fluorodeoxy-D-glucose positron emission tomography and computed tomography in the early detection of persistent/recurrent thyroid carcinoma in intermediate-to-high risk patients following initial radioactive iodine ablation therapy.
Kim MH; O JH; Ko SH; Bae JS; Lim DJ; Kim SH; Baek KH; Lee JM; Kang MI; Cha BY; Lee KW
Thyroid; 2012 Feb; 22(2):157-64. PubMed ID: 22224820
[TBL] [Abstract][Full Text] [Related]
9. Effect of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography-guided management of suspected recurrent papillary thyroid carcinoma: long-term follow-up with tumour marker responses.
Dennis K; Hay JH; Wilson DC
Clin Oncol (R Coll Radiol); 2012 Dec; 24(10):e168-72. PubMed ID: 22944464
[TBL] [Abstract][Full Text] [Related]
10. A risk-adapted approach using US features and FNA results in the management of thyroid incidentalomas identified by 18F-FDG PET.
Choi JS; Choi Y; Kim EK; Yoon JH; Youk JH; Han KH; Moon HJ; Kang WJ; Kwak JY
Ultraschall Med; 2014 Feb; 35(1):51-8. PubMed ID: 24458573
[TBL] [Abstract][Full Text] [Related]
11. Combined [18F]Fluorodeoxyglucose positron emission tomography and computed tomography (FDG-PET/CT) for detection of recurrent, 131I-negative thyroid cancer.
Finkelstein SE; Grigsby PW; Siegel BA; Dehdashti F; Moley JF; Hall BL
Ann Surg Oncol; 2008 Jan; 15(1):286-92. PubMed ID: 17882493
[TBL] [Abstract][Full Text] [Related]
12. Review. 18F-FDG PET in the diagnosis and follow-up of thyroid malignancy.
Al-Nahhas A; Khan S; Gogbashian A; Banti E; Rampin L; Rubello D
In Vivo; 2008; 22(1):109-14. PubMed ID: 18396792
[TBL] [Abstract][Full Text] [Related]
13. Follow-up in patients with differentiated thyroid carcinoma with positive 18F-fluoro-2-deoxy-D-glucose-positron emission tomography results, elevated thyroglobulin levels, and negative high-dose 131I posttreatment whole body scans.
van Tol KM; Jager PL; Dullaart RP; Links TP
J Clin Endocrinol Metab; 2000 May; 85(5):2082-3. PubMed ID: 10843201
[No Abstract] [Full Text] [Related]
14. Recombinant human thyrotropin stimulation of fluoro-D-glucose positron emission tomography uptake in well-differentiated thyroid carcinoma.
Chin BB; Patel P; Cohade C; Ewertz M; Wahl R; Ladenson P
J Clin Endocrinol Metab; 2004 Jan; 89(1):91-5. PubMed ID: 14715833
[TBL] [Abstract][Full Text] [Related]
15. Clinical and pathological factors related to 18F-FDG-PET positivity in the diagnosis of recurrence and/or metastasis in patients with differentiated thyroid cancer.
London K; Lin M
Ann Surg Oncol; 2011 Jan; 18(1):291. PubMed ID: 20505997
[No Abstract] [Full Text] [Related]
16. Diagnosis of metastases from postoperative differentiated thyroid cancer: comparison between FDG and FLT PET/CT studies.
Nakajo M; Nakajo M; Jinguji M; Tani A; Kajiya Y; Tanabe H; Fukukura Y; Nakabeppu Y; Koriyama C
Radiology; 2013 Jun; 267(3):891-901. PubMed ID: 23468571
[TBL] [Abstract][Full Text] [Related]
17. Real-time prognosis for metastatic thyroid carcinoma based on 2-[18F]fluoro-2-deoxy-D-glucose-positron emission tomography scanning.
Robbins RJ; Wan Q; Grewal RK; Reibke R; Gonen M; Strauss HW; Tuttle RM; Drucker W; Larson SM
J Clin Endocrinol Metab; 2006 Feb; 91(2):498-505. PubMed ID: 16303836
[TBL] [Abstract][Full Text] [Related]
18. Clinical and pathological factors related to 18F-FDG-PET positivity in the diagnosis of recurrence and/or metastasis in patients with differentiated thyroid cancer.
Esteva D; Muros MA; Llamas-Elvira JM; Jiménez Alonso J; Villar JM; López de la Torre M; Muros T
Ann Surg Oncol; 2009 Jul; 16(7):2006-13. PubMed ID: 19415387
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic accuracy of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in differentiated thyroid cancer patients with elevated thyroglobulin and negative (131)I whole body scan: evaluation by thyroglobulin level.
Na SJ; Yoo IeR; O JH; Lin C; Lin Q; Kim SH; Chung SK
Ann Nucl Med; 2012 Jan; 26(1):26-34. PubMed ID: 21971605
[TBL] [Abstract][Full Text] [Related]
20. Diagnosis of incidental thyroid nodules on 18F-fluorodeoxyglucose positron emission tomography imaging: are these significant?
Sharma SD; Jacques T; Smith S; Watters G
J Laryngol Otol; 2015 Jan; 129(1):53-6. PubMed ID: 25496842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
